Accès gratuit
Med Sci (Paris)
Volume 24, Numéro 1, Janvier 2008
Page(s) 65 - 71
Section M/S revues
Publié en ligne 15 janvier 2008
  1. Wang L, Ho CL, Sun D, et al. Rapid movement of axonal neurofilaments interrupted by prolonged pauses. Nat Cell Biol 2000; 2 : 137–41. [Google Scholar]
  2. Millecamps S, Gowing G, Corti, et al. Conditional NF-L transgene expression in mice for in vivo analysis of turnover and transport rate of neurofilaments. J Neurosci 2007; 27 : 4947–56. [Google Scholar]
  3. Reid E, Kloos M, Ashley-Koch A, et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 2002; 71 : 1189–94. [Google Scholar]
  4. Xia CH, Roberts EA, Her LS, et al. Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. J Cell Biol 2003; 161 : 55–66. [Google Scholar]
  5. Zhao C, Takita J, Tanaka Y, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 2001; 105 : 587–97. [Google Scholar]
  6. Zuchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004; 36 : 449–51. [Google Scholar]
  7. Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, et al. Mutant dynactin in motor neuron disease. Nat Genet 2003; 33 : 455–6. [Google Scholar]
  8. LaMonte BH, Wallace KE, Holloway BA, et al. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 2002; 34 : 715–27. [Google Scholar]
  9. Hafezparast M, Klocke R, Ruhrberg C, et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 2003; 300 : 808–12. [Google Scholar]
  10. Mersiyanova IV, Perepelov AV, Polyakov AV, et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 2000; 67 : 37–46. [Google Scholar]
  11. Perez-Olle R, Lopez-Toledano MA, Goryunov D, et al. Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport. J Neurochem 2005; 93 : 861–74. [Google Scholar]
  12. Figlewicz DA, Krizus A, Martinoli MG, et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3 : 1757–61. [Google Scholar]
  13. Côté F, Collard JF, Julien JP. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene : a mouse model of amyotrophic lateral sclerosis. Cell 1993; 73 : 35–46. [Google Scholar]
  14. Kriz J, Meier J, Julien JP, et al. Altered ionic conductances in axons of transgenic mouse expressing the human neurofilament heavy gene : A mouse model of amyotrophic lateral sclerosis. Exp Neurol 2000; 163 : 414–21. [Google Scholar]
  15. Collard JF, Côté F, Julien JP. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 1995; 375 : 61–4. [Google Scholar]
  16. Gros-Louis F, Lariviere R, Gowing G, et al. A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis. J Biol Chem 2004; 279 : 45951–6. [Google Scholar]
  17. Robertson J, Doroudchi MM, Nguyen MD, et al. A neurotoxic peripherin splice variant in a mouse model of ALS. J Cell Biol 2003; 160 : 939–49. [Google Scholar]
  18. Beaulieu JM, Nguyen MD, Julien JP. Late onset death of motor neurons in mice overexpressing wild-type peripherin. J Cell Biol 1999; 147 : 531–44. [Google Scholar]
  19. Millecamps S, Robertson J, Lariviere R, et al. Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin. J Neurochem 2006; 98 : 926–38. [Google Scholar]
  20. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5’-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393 : 702–5. [Google Scholar]
  21. Ishihara T, Hong M, Zhang B, et al. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 1999; 24 : 751–62. [Google Scholar]
  22. Julien JP, Kriz J. Transgenic mouse models of amyotrophic lateral sclerosis. Biochim Biophys Acta 2006; 1762 : 1013–24. [Google Scholar]
  23. Hazan J, Fonknechten N, Mavel D, et al. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet 1999; 23 : 296–303. [Google Scholar]
  24. Casari G, De Fusco M, Ciarmatori S, et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1998; 93 : 973–83. [Google Scholar]
  25. Errico A, Ballabio A, Rugarli EI. Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. Hum Mol Genet 2002; 11 : 153–63. [Google Scholar]
  26. Ferreirinha F, Quattrini A, Pirozzi M, et al. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J Clin Invest 2004; 113 : 231–42. [Google Scholar]
  27. Nishimura AL, Mitne-Neto M, Silva HC, et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 2004; 75 : 822–31. [Google Scholar]
  28. Hadano S, Hand CK, Osuga H, et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 2001; 29 : 166–73. [Google Scholar]
  29. Yang Y, Hentati A, Deng HX, et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 2001; 29 : 160–5. [Google Scholar]
  30. Otomo A, Hadano S, Okada T, et al. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. Hum Mol Genet 2003; 12 : 1671–87. [Google Scholar]
  31. Millecamps S, Gentil BJ, Gros-Louis F, et al. Alsin is partially associated with centrosome in human cells. Biochim Biophys Acta 2005; 1745 : 84–100. [Google Scholar]
  32. Verhoeven K, De Jonghe P, Coen K, et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 2003; 72 : 722–7. [Google Scholar]
  33. Lai C, Xie C, McCormack SG, et al. Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking. J Neurosci 2006; 26 : 11798–806. [Google Scholar]
  34. Cai H, Lin X, Xie C, et al. Loss of ALS2 function is insufficient to trigger motor neuron degeneration in knock-out mice but predisposes neurons to oxidative stress. J Neurosci 2005; 25 : 7567–74. [Google Scholar]
  35. Hadano S, Benn SC, Kakuta S, et al. Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. Hum Mol Genet 2006; 15 : 233–50. [Google Scholar]
  36. Devon RS, Orban PC, Gerrow K, et al. Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities. Proc Natl Acad Sci USA 2006; 103 : 9595–600. [Google Scholar]
  37. Yamanaka K, Miller TM, McAlonis-Downes M, et al. Progressive spinal axonal degeneration and slowness in ALS2-deficient mice. Ann Neurol 2006; 60 : 95–104. [Google Scholar]
  38. Williamson TL, Cleveland DW. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci 1999; 2 : 50–6. [Google Scholar]
  39. Zhang B, Tu P, Abtahian F, et al. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J Cell Biol 1997; 139 : 1307–15. [Google Scholar]
  40. Kieran D, Hafezparast M, Bohnert S, et al. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J Cell Biol 2005; 169 : 561–7. [Google Scholar]
  41. Millecamps S, Nicolle D, Ceballos-Picot I, et al. Synaptic sprouting increases the uptake capacities of motoneurons in amyotrophic lateral sclerosis mice. Proc Natl Acad Sci USA 2001; 98 : 7582–7. [Google Scholar]
  42. Teuchert M, Fischer D, Schwalenstoecker B, et al. A dynein mutation attenuates motor neuron degeneration in SOD1(G93A) mice. Exp Neurol 2006; 198 : 271–4. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.